LINC00520 and Miyoshi myopathy: Generally, cancer patients with lower LINC00520 expression levels have a higher overall survival rate (OS), including lung cancer (11), LUAD (13), NSCLC (10), PTC (14), CRC (15), MM (16, 18), and NPC (21).